肿瘤学博士。本科毕业于西安交通大学 临床医学系,硕士毕业于北京协和医学院中国医学科学院肿瘤医院 肿瘤学专业,博士毕业于中山大学肿瘤防治中心 肿瘤学专业,师从马骏院士,对鼻咽癌的综合治疗有深入研究。为深圳市特聘人才,从事肿瘤综合治疗研究十余年,以第一作者/通讯作者在J Oncol.,Radiat Oncol.,Front Oncol.等杂志发表SCI论文数篇,参与多项国家自然科学基金、北京市自然科学基金、北京市科技计划课题、北京市马拉松课题、广东省自然科学基金、广东省医学科研基金等。
科研成果
第一作者及通讯作者文章1.Wu YL, Li WF, Yang KB, Chen L, Shi JR, Chen FP, Huang XD, Lin L, Zhang XM, Li J, Chen YP, Tang LL, Mao YP, Ma J. Long-Term Evaluation and Normal Tissue Complication Probability (NTCP) Models for Predicting Radiation-Induced Optic Neuropathy after Intensity-Modulated Radiation Therapy (IMRT) for Nasopharyngeal Carcinoma: A Large Retrospective Study in China. J Oncol. 2022 Feb 23;2022:3647462. 2.Wu YL, Zhai Y, Li M, Cai JQ, Ma P, Wang LM, Wu XH, Wang XD, Wu F, Zeng Q, Chen B, Li YX, Wu JX, Feng Q. Long-Term Outcome of Centrally Located Hepatocellular Carcinomas Treated by Radical Resection Combined With Intraoperative Electron Radiotherapy (IOERT). Front Oncol. 2022 Feb 11;12:773301.3.Wu YL, Yang KB, Huang Y, Shi JR, He QS, Chen L, Li WF, Huang XD, Lin L, Chen YP, Mao YP, Tang LL, Ma J. Selection and validation of chemotherapy beneficiaries among elderly nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiation therapy (IMRT): a large real-world study. Radiat Oncol. 2022 Aug 8;17(1):138. 4.He S, Wu YL, Gao Y, He D, Huang Y. Risk stratification and beneficiary selection among elderly nasopharyngeal carcinoma patients from concurrent chemoradiotherapy combined with induction chemotherapy. Cancer Med. 2023 Apr 16.
暂无文字分享。
暂无文字分享。
暂无文字分享。